Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Curr Opin Psychiatry. Author manuscript; available in PMC 2014 July 15.
Published in final edited form as:
PMCID: PMC4096990

Psychological Treatments for Eating Disorders

Andrea E. Kass, M.A.,1 Rachel P. Kolko, M.A.,1 and Denise E. Wilfley, Ph.D.1,2,*


Purpose of review

This review summarizes recent evidence on psychological treatments for eating disorders (EDs).

Recent findings

EDs are serious psychiatric conditions requiring evidence-based intervention. Treatments have been evaluated within each ED diagnosis and across diagnoses. For adults with anorexia nervosa, no one specialist treatment has been shown to be superior. Cognitive behavioral therapy (CBT) and interpersonal psychotherapy (IPT) remain the most established treatments for bulimia nervosa and binge eating disorder, with stepped-care approaches showing promise and new behavioral treatments under study. Transdiagnostic enhanced CBT has improved symptoms in adults and youth. Maudsley family-based therapy is the most established treatment for youth with anorexia nervosa and may be efficacious for youth with bulimia nervosa. IPT for the prevention of excess weight gain may be efficacious for reducing loss of control eating and weight gain in overweight youth.


Significant advances in treatments have been made, including evaluation of long-term outcomes, novel approaches, and tailored extension for specific patient profiles. However, widespread access to effective ED treatments remains limited. Increasing the potency and expanding the implementation of psychological treatments beyond research settings into clinical practice has strong potential to increase access to care, thereby reducing the burden of EDs.

Keywords: eating disorders, psychological treatments, evidence-based treatment


This review discusses evidence-based psychological treatments for anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), and subclinical diagnoses, with a focus on clinical research updates from the past 18 months. Future directions for eating disorder (ED) treatment research are provided, including strategies to increase the potency, dissemination, and implementation of evidence-based treatments.


Updates on treatments for adults with AN, BN, and BED are reviewed.

Anorexia Nervosa

AN in adults is often persistent in course (1), and no one specialist treatment has been shown to be superior (2), with results primarily focused on short-term findings.

Cognitive behavioral therapy (CBT: targeting the distorted thoughts and maladaptive behaviors that maintain ED symptoms) and interpersonal psychotherapy (IPT: targeting the interpersonal difficulties that maintain ED symptoms) are specialist psychological treatments that address AN symptomatology. The efficacy of CBT and IPT for adults with AN was evaluated against a comparison treatment, specialist supportive clinical management (SSCM, an ED education intervention focused on weight restoration) in a randomized controlled trial (RCT). Long-term findings revealed that 49% of patients evidenced a good outcome (i.e., minimal to no AN symptoms), but no treatment emerged as most efficacious (3). Across follow-up, the percentage of patients with good outcome remained stable with CBT (41%), improved with IPT (64%), and declined with SSCM (42%). Results from the trial suggest that further evaluation using a stepped care approach may be warranted, to evaluate whether providing a treatment focused on targeting ED features and restoring weight (e.g., SSCM) and then providing a treatment focused on factors that maintain the disorder in a broader context (e.g., IPT) is advantageous (3).

Given high rates of non-response, Maudsley Model of Treatment for Adults with Anorexia Nervosa (MANTRA) was developed based on a maintenance model of AN, aimed to address cognitive distortions about the utility of AN and rigidity, socio-emotional deficits, and parents/partners’ enabling behaviors MANTRA was evaluated against SSCM in a RCT (4). MANTRA and SSCM yielded symptom improvements, and the proportion of patients with global Eating Disorder Examination (EDE) scores within one standard deviation of the community mean (below 1.74) at 12-month follow-up was 59% in MANTRA and 73% in SSCM; however, across outcomes, the two conditions were not significantly different (4). A large-scale trial of MANTRA and SSCM is underway to evaluate long-term comparative efficacy of these treatments (given that SSCM effects decline over time (3)), subgroup analyses, and cost-effectiveness (5).

Taken together, these data suggest that patients improve with specialty treatments, but a subset remains symptomatic, warranting novel approaches to improve rates of AN symptom remission and increase the rapidity of treatment response. Cognitive remediation therapy (CRT) addresses the impaired cognition that may contribute to the maintenance of AN, and may reduce dropout and improve outcomes through increased treatment engagement and improved cognitive flexibility (6). CRT literature in adults has focused on small case series (68), and a small RCT did not demonstrate the added benefit of including CRT prior to CBT (although improvements in cognitive functioning were greater in the CRT+CBT condition), but suggested that investigation of CRT in RCTs is feasible (9). Continued investigation of CRT is needed with more adequately powered studies, given its preliminary evidence of improved cognitive functioning and patient acceptability (6, 9).

Among patients with severe and enduring AN, treatments that focus on recovery may not match patients’ readiness to improve and can result in dropout (10). A novel approach for this population may be to focus on improving treatment retention and quality of life rather than on ED recovery (10). A RCT was conducted among women with severe and enduring AN (defined as ≥7 years) using CBT-AN and SSCM, adapted such that the primary focus of both treatments was on improving quality of life but not weight gain specifically (10). Health-related quality of life and ED outcomes improved in both conditions, but at follow-up, CBT-AN had better social adjustment, ED symptoms, and readiness to change. Further, 87% completed treatment and 85% completed follow-up assessments, representing the highest retention rate of any treatment trial of adults with AN (10). The results suggests that individuals with severe and enduring AN may respond to and improve with specialty treatments (10).

Bulimia Nervosa

CBT is most well-established for the treatment of BN, with IPT demonstrating equivalent long-term effects (1115).

Recent Updates

Despite the equivalent efficacy of IPT to CBT, the time course for IPT has been shown to be slower than CBT (12). It has been noted that various implementations of IPT may have attenuated therapeutic effects by failing to discuss ED symptoms (and link them to interpersonal contexts) or removing IPT techniques that overlap with CBT (15, 16). IPT has since been modified for clinical use (i.e., IPT-BNm) to more comprehensively address bulimic EDs (i.e., BN, BED, and subclinical EDs with bulimic features), with preliminary efficacy in a pilot case series (16). Given demands for time-limited therapies, IPT-BNm was subsequently modified to a brief, 10-session delivery (IPT-BN10) (17). Thirty patients with bulimic disorders were randomized into IPT-BN10, IPT-BNm, or wait-list control. IPT-BN10 and IPT-BNm outcomes did not differ, but were better than wait-list control, suggesting that IPT-BN10 may be feasible and warrants additional study (17).

Given that efficacious specialty treatments are not being implemented in routine practice, a stepped care trial was conducted to evaluate whether efficacious treatments that do not require specialist care can be used in a stepped-care sequence, potentially increasing ease of dissemination. A stepped-care group (“stepped care”; consisting of assisted self-help followed by adjunctive fluoxetine and then CBT) was compared to a CBT group (“CBT”; consisting of CBT followed by adjunctive fluoxetine) in a RCT (18). Remission rates did not significantly differ at 1-year follow-up (32% for stepped-care; 44% for CBT), but stepped-care was more efficacious than CBT in reducing binge eating and compensatory behaviors. Among those predicted as non-responders, abstinence rates were higher in stepped-care (25%) than CBT (4%) (18). Stepped-care was more cost-effective than CBT (19). Results indicate that, if used in a stepped-care sequence, assisted self-help may be a possible alternative to CBT, and that stepped-care may be an effective approach among patients predicted as non-responders (18). Further evaluation of stepped-care order and patient profiles for whom specific components are effective are next steps.

Integrative cognitive-affective therapy (ICAT) for BN aims to enhance treatment efficacy by addressing ED maintaining factors, specifically emotion, self-oriented cognition, and nutritional rehabilitation (20). ICAT was compared to an enhanced version of CBT (CBT-E; see Transdiagnostic Treatment for Eating Disorders). Symptoms improved, but treatments were not significantly different. Binge-purge abstinence rates (32.5% for ICAT; 22.5% for CBT-E) and percent of patients within 1 standard deviation of global EDE score community mean (below 1.74; 55.0% for ICAT; 50.0% for CBT-E) were also not significantly different at 4-month follow-up (20). Further evaluation of ICAT, including assessment of long-term outcomes, is warranted.

Binge Eating Disorder

CBT and IPT are efficacious for BED, with greater results than behavioral weight loss (BWL) (2123). BWL has demonstrated mixed findings regarding BED outcomes and weight loss (21, 22, 24).

Recent Updates

IPT and CBT have been shown to be effective at 1- and 2-year follow-up. To extend these findings and evaluate stability of treatment effects, 5-year outcomes were examined (23). Results showed CBT and IPT were similarly effective in long-term recovery rates (i.e., no objective binge episodes: 52.0% for CBT and 76.7% for IPT). The treatments did not differ from one another at any time point, suggesting both IPT and CBT are effective treatments for BED (23).

Long-term outcomes of CBT compared to fluoxetine and CBT+fluoxetine indicated that CBT (i.e., CBT+fluoxetine and CBT+placebo), but not fluoxetine, resulted in sustained effects on remission from binge eating (45.5% for CBT+placebo, 36.8% for CBT+fluoxetine, and 5.9% for fluoxetine)(25). Thus, CBT was more effective than fluoxetine, and adjunctive fluoxetine did not add benefit to CBT. Further investigation of patient profiles that predict long-term response to CBT is warranted.

Transdiagnostic Treatment for Eating Disorders

Expanding treatment to more broadly address features that maintain EDs may improve symptoms among non-responders (26). Moreover, because EDs share psychopathology and patients often move between diagnoses, a treatment that is applicable for all EDs may enhance the scalability of outpatient specialist treatments (26). For these reasons, CBT was enhanced into a transdiagnostic treatment (CBT-E) (27).

Recent Updates

CBT-E has demonstrated improvements in patients with BMI>17.5 in an efficacy RCT with 60-week follow-up and an effectiveness open trial evaluating post-treatment outcomes (27, 28). To evaluate CBT-E specifically among patients at low weight, outpatients with BMI<17.5 were treated with CBT-E (29). Two-thirds of patients completed treatment, of whom 62% achieved BMI>18.5 and 88% had a global EDE score within 1 standard deviation of the community mean (below 2.77). Effects slightly deteriorated by 60-week follow-up (55% had BMI>18.5 and 78% had global EDE within 1 SD of the community mean) (29). Evaluating CBT-E against comparison treatments in RCTs is indicated.

Additional Treatments for Eating Disorders in Adults

Other treatments for EDs are under study and warrant discussion. Exposure and response prevention approaches have been previously evaluated and recently revisited in a RCT with patients with BN (30) and an open series with nine patients with AN (31); replication of the findings is warranted (32). Dialectical behavior therapy (DBT) is under investigation for treatment of EDs, though most results have been obtained from uncontrolled trials (33). Large-scale RCTs evaluating the efficacy of DBT, particularly in comparison to specialist treatment, are warranted. Motivational interviewing (MI) interventions have been used to increase retention, given high dropout in ED trials (34). However, reviews of MI suggest it is not well supported for ED treatment (3537).


Intervening with youth represents an ideal target, as EDs typically onset in adolescence and treatments can capitalize on parental/family involvement (38). Maudsley FBT is the most established treatment for youth with AN (50% remission rate, defined as normal weight and normal EDE) and may be efficacious for youth with BN (approximately 30% remission rate, defined as no binge or purge episodes) (39, 40), although it is important to identify treatments for adolescents who do not respond to FBT, as no such treatment currently exists (41). Given the relation between binge eating, excess weight/obesity, and depression (42), IPT for the prevention of excess weight gain (IPT-WG) has reduced loss of control eating and weight gain in overweight adolescents in a pilot trial (43), and a large-scale study is underway.

Recent Updates

Maudsley FBT was compared to individual adolescent focused therapy (AFT), and recent moderator analyses suggest that patients with more severe psychopathology demonstrated greater remission (≥95% ideal body weight and scores within 1 standard deviation of EDE global norms) in FBT at end-of-treatment, whereas patients with AN binge/purge type had better remission in FBT at 6- to 12-month follow-up (44). In addition, family therapy focused on intra-familial dynamics (rather than ED symptom-focused, behaviorally-oriented FBT) was evaluated as an adjunctive intervention to treatment-as-usual (TAU) (45). TAU+family therapy yielded improvements over TAU on had ratings of good or intermediate outcomes (via the Morgan and Russell outcome scale; 40% vs. 17.2%), achievement of healthy weight (53.4% vs. 27.6%), and amenorrhea (36.7% vs. 65.5%) (45).

One study has evaluated CBT-E among adolescents with AN (46), although it lacked a comparison condition. Similar to adults with AN (29), two-thirds of participants completed treatment and demonstrated significant improvements in weight (28.3% achieved 95% of expected body weight) and reductions in eating pathology (76.7% <1 standard deviation above the EDE global community norm), at 60-week follow-up (46). Further investigation of CBT-E, including comparison to FBT, is warranted (46).

Group-based treatments continue to be evaluated, as the group setting offers opportunities to practice social skills and may be cost-effective. Group CRT has been evaluated in both intensive outpatient and inpatient settings, with adolescents demonstrating increased cognitive flexibility (47, 48) and increased ability on specific cognitive tasks (48), as well as positive feedback and acceptability (47, 48). Group CBT was adapted for adolescent girls with recurrent binge eating and tested in a small pilot trial of CBT vs. TAU+delayed CBT: all adolescents evidenced abstinence from objective binge eating following CBT (49). IPT-WG, which is delivered in a group format, is currently being adapted for rural African American girls and their parents/guardians; preliminary data suggest that participants identified IPT-WG as an acceptable treatment concept, with recommendations for specific cultural adaptations as well as inclusion of behavioral and parent components (50).


Strides have been made to establish evidence-based ED treatments. However, a subset of patients does not improve (14), and many patients do not receive evidence-based treatments in routine care (51, 52). Two overarching future directions for treatment research include making ED treatments maximally potent and maximally implementable.

Maximizing Treatment Potency

Honing our understanding of the factors that maintain EDs and predict patient treatment response may inform development of novel treatment targets. Examining moderators and mediators can be useful for determining for whom and how treatments are most effective. The Research Domain Criteria (RDoC) project aims to bridge neuroscience and genetics to inform diagnostic classification and clinical management (53). RDoC may be a useful framework for EDs and is currently being applied to treatment for BED/pediatric binge eating through examination of genetics, appetitive hormones, and brain imaging that may be involved in the onset and maintenance of the disorder and contribute to heterogeneous symptom presentations (22, 54). Neuromodulation techniques are under evaluation and may help clarify neurobiological mechanisms of EDs (5557). One strength is the potential for neuromodulation to be an adjunctive treatment, as neuroplastic changes may “boost” psychotherapy effects (55). Combined, these approaches may help to improve our understanding of mechanisms by which ED treatments work, which can inform questions regarding for whom treatments are most efficacious and under what conditions.

Maximizing Treatment Implementation

Scaling efficacious treatments for widespread implementation is a priority, as the need for treatment far outweighs the availability of resources to deliver evidence-based care (52, 58). Treatments must be designed, adapted, and evaluated for their ability to be disseminated and implemented across multiple settings, as the research settings in which most treatments are developed often differ from routine care settings in which treatment is delivered (52).

Partnering with stakeholders to evaluate the uptake, cost-effectiveness, and sustainability of evidence-based treatments is critical (59) as well as building capacity among existing front-line service providers to deliver early ED screening and treatment (58, 60). Training strategies (e.g., “train-the-trainer”) that extend routine training and supervision may accomplish this aim (61); online training offers the possibility for extending the reach of training (62).

Use of guided self-help (GSH) (63) and technology-based treatments (6466) may also increase ED identification and care delivery, as they rely less on specialists and are therefore more scalable than specialist approaches. Another advantage to these treatments is the potential for integration within stepped-care, population-based models, resulting in comprehensive systems for care delivery that conserve specialist resources for those most in need (67). Critical future directions to evaluate GSH and technology-based approaches include a) evaluating opportunities to enhance the effectiveness and implement GSH treatment, b) determining optimal levels of training/expertise for GSH providers, and c) examining the efficacy, effectiveness, and cost-effectiveness of technology-based treatments (63, 64, 67).


The ED field continues to hone psychological treatments, but evaluating long-term outcomes and identifying treatments for the subset of patients who remain symptomatic represent critical future directions. Continued efforts to incorporate novel technologies into treatments and effectively train, disseminate, and implement ED treatments will increase access to evidence-based care, thereby reducing the burden of EDs.


  • Though no one specialist treatment has been shown to be superior for treatment of adults with anorexia nervosa, a considerable number of patients improve with specialist psychological treatments.
  • Cognitive behavioral therapy and interpersonal psychotherapy remain most efficacious for treatment of adults with bulimia nervosa, and treatment delivered in a stepped-care approach may be promising.
  • Long-term efficacy has been established for cognitive behavioral therapy and interpersonal psychotherapy for treatment of adults with binge eating disorder.
  • Family-based therapy is the most established treatment for youth with anorexia nervosa and may be efficacious for youth with bulimia nervosa; interpersonal psychotherapy for the prevention of excess weight gain may be efficacious for reducing loss of control eating and weight gain in overweight adolescents.
  • Efforts to improve the potency (by targeting key maintaining factors) and expand the implementation of evidence-based treatments (by scaling treatments for widespread delivery) are critical.


The authors thank Grace Monterubio for assistance with literature reviews.

This work was supported by grant T32 HL007456 from the National Heart, Lung, and Blood Institute and grant K24 MH070446 from the National Institute of Mental Health.


Conflict of interest

There are no conflicts of interest.


1. Walsh BT. The enigmatic persistence of anorexia nervosa. Am J Psychiatry. 2013 May 1;170(5):477–484. PubMed PMID: 23429750. [PubMed] This paper presents evidence for a model to elucidate the persistent course of anorexia nervosa.
2. Watson HJ, Bulik CM. Update on the treatment of anorexia nervosa: review of clinical trials, practice guidelines and emerging interventions. Psychol Med. 2012 Dec;10:1–24. PubMed PMID: 23217606. [PubMed] This paper reviews treatment research and practice guidelines for anorexia nervosa, with the goal of informing clinical practice for this patient population.
3. Carter FA, Jordan J, McIntosh VV, Luty SE, McKenzie JM, Frampton CM, et al. The long-term efficacy of three psychotherapies for anorexia nervosa: a randomized, controlled trial. Int J Eat Disord. 2011 Nov;44(7):647–654. PubMed PMID: 21997429. [PubMed]
4. Schmidt U, Oldershaw A, Jichi F, Sternheim L, Startup H, McIntosh V, et al. Out-patient psychological therapies for adults with anorexia nervosa: randomised controlled trial. Br J Psychiatry. 2012 Nov;201(5):392–399. PubMed PMID: 22995632. Epub 2012/09/22. eng. [PubMed]
5. Schmidt U, Renwick B, Lose A, Kenyon M, Dejong H, Broadbent H, et al. The MOSAIC study - comparison of the Maudsley Model of Treatment for Adults with Anorexia Nervosa (MANTRA) with Specialist Supportive Clinical Management (SSCM) in outpatients with anorexia nervosa or eating disorder not otherwise specified, anorexia nervosa type: study protocol for a randomized controlled trial. Trials. 2013 May 30;14(1):160. PubMed PMID: 23721562. [PubMed] This paper outlines the study protocol for the largest trial comparing MANTRA (Maudsley Model of Treatment for Adults with Anorexia Nervosa) to a specialist supportive clinical management intervention, given the lack of evidence-based treatments for anorexia nervosa.
6. Tchanturia K, Lloyd S, Lang K. Cognitive remediation therapy for anorexia nervosa: Current evidence and future research directions. Int J Eat Disord. 2013 Jul;46(5):492–495. PubMed PMID: 23658098. Epub 2013/05/10. eng. [PubMed] This paper summarizes current evidence in the literature applying cognitive remediation therapy to anorexia nervosa, and outlines novel directions for this area of treatment research.
7. Davies H, Fox J, Naumann U, Treasure J, Schmidt U, Tchanturia K. Cognitive remediation and emotion skills training for anorexia nervosa: an observational study using neuropsychological outcomes. Eur Eat Disord Rev. 2012 May;20(3):211–217. PubMed PMID: 22431401. [PubMed]
8. Abbate-Daga G, Buzzichelli S, Marzola E, Amianto F, Fassino S. Effectiveness of cognitive remediation therapy (CRT) in anorexia nervosa: a case series. J Clin Exp Neuropsychol. 2012 Dec;34(10):1009–1015. PubMed PMID: 22876988. [PubMed]
9. Lock J, Agras WS, Fitzpatrick KK, Bryson SW, Jo B, Tchanturia K. Is outpatient cognitive remediation therapy feasible to use in randomized clinical trials for anorexia nervosa? Int J Eat Disord. 2013 Apr;:29. PubMed PMID: 23625628. [PMC free article] [PubMed]
10. Touyz S, Le Grange D, Lacey H, Hay P, Smith R, Maguire S, et al. Treating severe and enduring anorexia nervosa: a randomized controlled trial. Psychol Med. 2013 May;3:1–11. PubMed PMID: 23642330. Epub 2013/05/07. Eng. This paper demonstrates the promise of psychological treatments with a population of patients with severe and enduring anorexia nervosa, given that illness chronicity is associated with poorer treatment response.
11. Fairburn CG, Jones R, Peveler RC, Hope RA, O'Connor M. Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy. Arch Gen Psychiatry. 1993 Jun;50(6):419–428. PubMed PMID: 8498876. [PubMed]
12. Agras WS, Walsh BT, Fairburn CG, Wilson GT, Kraemer HC. A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Archives of General Psychiatry. 2000;57(5):459–466. [PubMed]
13. Hay P. A systematic review of evidence for psychological treatments in eating disorders: 2005–2012. Int J Eat Disord. 2013 Jul;46(5):462–469. PubMed PMID: 23658093. Epub 2013/05/10. eng. [PubMed] This paper provides a comprehensive review and update of eating disorder treatment literature from past seven years adding new evidence for psychotherapies in eating disorders.
14. Brown TA, Keel PK. Current and emerging directions in the treatment of eating disorders. Substance abuse : research and treatment. 2012;6:33–61. PubMed PMID: 22879753. Pubmed Central PMCID: 3411516. [PubMed] This paper provides a comprehensive discussion of current and emerging treatments for eating disorder treatments.
15. Rieger E, Van Buren DJ, Bishop M, Tanofsky-Kraff M, Welch R, Wilfley DE. An eating disorder-specific model of interpersonal psychotherapy (IPT-ED): causal pathways and treatment implications. Clin Psychol Rev. 2010 Jun;30(4):400–410. PubMed PMID: 20227151. Epub 2010/03/17. eng. [PubMed]
16. Arcelus J, Whight D, Langham C, Baggott J, McGrain L, Meadows L, et al. A case series evaluation of a modified version of interpersonal psychotherapy (IPT) for the treatment of bulimic eating disorders: a pilot study. Eur Eat Disord Rev. 2009 Jul;17(4):260–268. PubMed PMID: 19452496. [PubMed] This paper introduces a brief, 10-session version of IPT for patients with BN BED, and subclinical EDs with bulimic symptoms.
17. Arcelus J, Whight D, Brewin N, McGrain L. A brief form of interpersonal psychotherapy for adult patients with bulimic disorders: a pilot study. Eur Eat Disord Rev. 2012 Jul;20(4):326–330. PubMed PMID: 22383297. [PubMed]
18. Mitchell JE, Agras S, Crow S, Halmi K, Fairburn CG, Bryson S, et al. Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial. The British Journal of Psychiatry. 2011;198(5):391–397. [PMC free article] [PubMed]
19. Crow SJ, Agras WS, Halmi KA, Fairburn CG, Mitchell JE, Nyman JA. A cost effectiveness analysis of stepped care treatment for bulimia nervosa. Int J Eat Disord. 2013 May;46(4):302–307. PubMed PMID: 23354913. [PMC free article] [PubMed]
20. Wonderlich SA, Peterson CB, Crosby RD, Smith TL, Klein MH, Mitchell JE, et al. A randomized controlled comparison of integrative cognitive-affective therapy (ICAT) and enhanced cognitive-behavioral therapy (CBT-E) for bulimia nervosa. Psychol Med. 2013 May;23:1–11. PubMed PMID: 23701891. [PubMed] This paper discusses the first randomized controlled trial to compare a new treatment for BN integrative cognitive-affective therapy (ICAT) and enhanced cognitive behavioral therapy (CBT-E) for bulimia nervosa.
21. Wilson GT, Wilfley DE, Agras WS, Bryson SW. Psychological treatments of binge eating disorder. Arch Gen Psychiatry. 2010 Jan;67(1):94–101. PubMed PMID: 20048227. [PMC free article] [PubMed]
22. Tanofsky-Kraff M, Bulik CM, Marcus MD, Striegel RH, Wilfley DE, Wonderlich SA, et al. Binge eating disorder: the next generation of research. Int J Eat Disord. 2013 Apr;46(3):193–207. PubMed PMID: 23354950. Pubmed Central PMCID: 3600071. [PubMed] This paper reviews the state of current knowledge on psychological treatments for binge eating disorder, as well as inclusion of support in the DSM-5, risk factors, comorbidity, Research Domain Criteria, obesity relationships, pharmacological and surgical treatments, military health, and personal costs in relation to binge eating disorder.
23. Hilbert A, Bishop ME, Stein RI, Tanofsky-Kraff M, Swenson AK, Welch RR, et al. Long-term efficacy of psychological treatments for binge eating disorder. Br J Psychiatry. 2012 Mar;200(3):232–237. PubMed PMID: 22282429. Pubmed Central PMCID: 3290797. [PubMed] This paper demonstrates the long-term efficacy of CBT and IPT for treatment of binge eating disorder, highlighting IPT as a viable alternative to CBT.
24. Munsch S, Meyer AH, Biedert E. Efficacy and predictors of long-term treatment success for Cognitive-Behavioral Treatment and Behavioral Weight-Loss-Treatment in overweight individuals with binge eating disorder. Behav Res Ther. 2012 Dec;50(12):775–785. PubMed PMID: 23099111. Epub 2012/10/27. eng. [PubMed]
25. Grilo CM, Crosby RD, Wilson GT, Masheb RM. 12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder. J Consult Clin Psychol. 2012 Dec;80(6):1108–1113. PubMed PMID: 22985205. Pubmed Central PMCID: PMC3514647. Epub 2012/09/19. eng. [PubMed] This paper discusses the long-term effects of cognitive behavioral therapy and pharmacotherapy (fluoxetine) in treating binge eating disorder, which demonstrated that cognitive behavioral therapy (alone or with adjunctive pharmacotherapy) was more effective than pharmacotherapy alone.
26. Fairburn CG, Cooper Z, Shafran R. Cognitive behaviour therapy for eating disorders: a "transdiagnostic" theory and treatment. Behav Res Ther. 2003 May;41(5):509–528. PubMed PMID: 12711261. [PubMed]
27. Fairburn CG, Cooper Z, Doll HA, O'Connor ME, Bohn K, Hawker DM, et al. Transdiagnostic cognitive-behavioral therapy for patients with eating disorders: a two-site trial with 60-week follow-up. Am J Psychiatry. 2009 Mar;166(3):311–339. PubMed PMID: 19074978. [PMC free article] [PubMed]
28. Byrne SM, Fursland A, Allen KL, Watson H. The effectiveness of enhanced cognitive behavioural therapy for eating disorders: an open trial. Behav Res Ther. 2011 Apr;49(4):219–226. PubMed PMID: 21345418. [PubMed]
29. Fairburn CG, Cooper Z, Doll HA, O'Connor ME, Palmer RL, Dalle Grave R. Enhanced cognitive behaviour therapy for adults with anorexia nervosa: a UK-Italy study. Behav Res Ther. 2013 Jan;51(1):R2–R8. PubMed PMID: 23084515. Pubmed Central PMCID: 3662032. [PubMed] This paper provides evidence of the sustained treatment effects of CBT-E among adults with anorexia nervosa, a population for whom no evidence-based treatment is established.
30. McIntosh VV, Carter FA, Bulik CM, Frampton CM, Joyce PR. Five-year outcome of cognitive behavioral therapy and exposure with response prevention for bulimia nervosa. Psychol Med. 2011 May;41(5):1061–1071. PubMed PMID: 20810005. [PubMed]
31. Steinglass J, Albano AM, Simpson HB, Carpenter K, Schebendach J, Attia E. Fear of food as a treatment target: exposure and response prevention for anorexia nervosa in an open series. Int J Eat Disord. 2012 May;45(4):615–621. PubMed PMID: 21541979. Pubmed Central PMCID: 3151474. [PubMed] This paper presents a novel adaptation of an evidence-based anxiety treatment to an eating disorder population, given the high comorbidity between eating disorders and anxiety.
32. Koskina A, Campbell IC, Schmidt U. Exposure therapy in eating disorders revisited. Neuroscience and biobehavioral reviews. 2013 Feb;37(2):193–208. PubMed PMID: 23201859. Epub 2012/12/04. eng. [PubMed] This paper provides a comprehensive review of exposure therapies evaluated with patients with eating disorders and provides novel directions for future research on these treatments.
33. Bankoff SM, Karpel MG, Forbes HE, Pantalone DW. A systematic review of dialectical behavior therapy for the treatment of eating disorders. Eat Disord. 2012 May;20(3):196–215. PubMed PMID: 22519897. [PubMed] This study reviews the literature on dialectical behavior therapy for eating disorders, and suggests the need for additional research to evaluate its efficacy.
34. Carter O, Pannekoek L, Fursland A, Allen KL, Lampard AM, Byrne SM. Increased wait-list time predicts dropout from outpatient enhanced cognitive behaviour therapy (CBT-E) for eating disorders. Behav Res Ther. 2012 Aug;50(7–8):487–492. PubMed PMID: 22659158. [PubMed]
35. Knowles L, Anokhina A, Serpell L. Motivational interventions in the eating disorders: what is the evidence? Int J Eat Disord. 2013 Mar;46(2):97–107. PubMed PMID: 23001832. Epub 2012/09/25. eng. [PubMed]
36. Dray J, Wade TD. Is the transtheoretical model and motivational interviewing approach applicable to the treatment of eating disorders? A review. Clin Psychol Rev. 2012 Aug;32(6):558–565. PubMed PMID: 22819997. Epub 2012/07/24. eng. [PubMed]
37. Waller G. The myths of motivation: time for a fresh look at some received wisdom in the eating disorders? Int J Eat Disord. 2012 Jan;45(1):1–16. PubMed PMID: 22170018. [PubMed] This paper counters the commonly-held view that patients’ verbal affirmations of motivation are helpful, and offers behavioral strategies to more effectively address motivation consistently throughout treatment.
38. Wilfley DE, Kolko RP, Kass AE. Cognitive-behavioral therapy for weight management and eating disorders in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2011 Apr;20(2):271–285. PubMed PMID: 21440855. Pubmed Central PMCID: 3065663. Epub 2011/03/29. eng. [PMC free article] [PubMed]
39. Stiles-Shields C, Hoste RR, Doyle PM, Le Grange D. A review of family-based treatment for adolescents with eating disorders. Reviews on recent clinical trials. 2012 May;7(2):133–440. PubMed PMID: 22353196. [PubMed] This paper provides a comprehensive review of family-based treatment research among adolescents with anorexia nervosa or bulimia nervosa.
40. Couturier J, Kimber M, Szatmari P. Efficacy of family-based treatment for adolescents with eating disorders: a systematic review and meta-analysis. Int J Eat Disord. 2013 Jan;46(1):3–11. PubMed PMID: 22821753. [PubMed] This meta-analytic review highlights the efficacy of family-based treatment at long-term follow-up.
41. Lock J. Evaluation of family treatment models for eating disorders. Current opinion in psychiatry. 2011 Jul;24(4):274–279. PubMed PMID: 21519263. [PubMed]
42. Sonneville KR, Horton NJ, Micali N, Crosby RD, Swanson SA, Solmi F, et al. Longitudinal associations between binge eating and overeating and adverse outcomes among adolescents and young adults: does loss of control matter? JAMA pediatrics. 2013 Feb;167(2):149–155. PubMed PMID: 23229786. Pubmed Central PMCID: 3654655. [PubMed] This paper highlights the association between binge eating, obesity, and dperession in a large sample of youth.
43. Tanofsky-Kraff M, Wilfley DE, Young JF, Mufson L, Yanovski SZ, Glasofer DR, et al. A pilot study of interpersonal psychotherapy for preventing excess weight gain in adolescent girls at-risk for obesity. Int J Eat Disord. 2010 Dec;43(8):701–706. PubMed PMID: 19882739. Pubmed Central PMCID: 2891416. Epub 2009/11/03. eng. [PMC free article] [PubMed]
44. Le Grange D, Lock J, Agras WS, Moye A, Bryson SW, Jo B, et al. Moderators and mediators of remission in family-based treatment and adolescent focused therapy for anorexia nervosa. Behav Res Ther. 2012 Feb;50(2):85–92. PubMed PMID: 22172564. Pubmed Central PMCID: 3260378. [PubMed] This paper discusses moderator analyses of treatment adolescents with anorexia nervosa, which indicated that patients with more severe eating psychopathology performed better in family-based therapy than adolescent focused therapy.
45. Godart N, Berthoz S, Curt F, Perdereau F, Rein Z, Wallier J, et al. A randomized controlled trial of adjunctive family therapy and treatment as usual following inpatient treatment for anorexia nervosa adolescents. PloS one. 2012;7(1):e28249. PubMed PMID: 22238574. Pubmed Central PMCID: 3251571. [PubMed] This study evaluates the role of family sessions in treatment of adolescents with anorexia nervosa.
46. Dalle Grave R, Calugi S, Doll HA, Fairburn CG. Enhanced cognitive behaviour therapy for adolescents with anorexia nervosa: an alternative to family therapy? Behav Res Ther. 2013 Jan;51(1):R9–R12. PubMed PMID: 23123081. Pubmed Central PMCID: 3662031. [PubMed] This paper discusses the long-term impact of transdiagnostic cognitive behavioral therapy for treatment of eating disorders in adolescents.
47. Pretorius N, Dimmer M, Power E, Eisler I, Simic M, Tchanturia K. Evaluation of a cognitive remediation therapy group for adolescents with anorexia nervosa: pilot study. Eur Eat Disord Rev. 2012 Jul;20(4):321–325. PubMed PMID: 22488792. [PubMed] This study evaluates the use of cognitive remediation therapy delivered in a group format for adolescents with anorexia nervosa.
48. Wood L, Al-Khairulla H, Lask B. Group cognitive remediation therapy for adolescents with anorexia nervosa. Clinical child psychology and psychiatry. 2011 Apr;16(2):225–231. PubMed PMID: 21571765. [PubMed]
49. Debar LL, Wilson GT, Yarborough BJ, Burns B, Oyler B, Hildebrandt T, et al. Cognitive Behavioral Treatment for Recurrent Binge Eating in Adolescent Girls: A Pilot Trial. Cognitive and behavioral practice. 2013 May 1;20(2):147–161. PubMed PMID: 23645978. Pubmed Central PMCID: 3640565. [PubMed] This paper presents results from a small pilot trial of CBT adapted for adolescent girls with recurrent binge eating.
50. Cassidy O, Sbrocco T, Vannucci A, Nelson B, Jackson-Bowen D, Heimdal J, et al. Adapting Interpersonal Psychotherapy for the Prevention of Excessive Weight Gain in Rural African American Girls. J Pediatr Psychol. 2013 May;22 PubMed PMID: 23678135. [PMC free article] [PubMed] This paper discusses cultural adaptations and implementation strategies, including incorporation of behavioral as well as parenting components, for delivery of interpersonal psychotherapy for the prevention of excessive weight gain among rural African American girls.
51. Wallace LM, von Ranson KM. Perceptions and use of empirically-supported psychotherapies among eating disorder professionals. Behav Res Ther. 2012 Mar;50(3):215–222. PubMed PMID: 22342168. [PubMed] This paper highlights the misperceptions to treatment delivery in routine clinical care and treatments as deployed in controlled treatment trials.
52. Kazdin AE, Blase SL. Rebooting Psychotherapy Research and Practice to Reduce the Burden of Mental Illness. Perspectives on Psychological Science. 2011;6(1):21–37.
53. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010 Jul;167(7):748–751. PubMed PMID: 20595427. [PubMed]
54. Tanofsky-Kraff M, Engel S, Yanovski JA, Pine DS, Nelson EE. Pediatric disinhibited eating: Toward a research domain criteria framework. Int J Eat Disord. 2013 Jul;46(5):451–455. PubMed PMID: 23658090. Epub 2013/05/10. eng. [PubMed] This paper describes the potential for adaptation of the novel RDoC framework to the assessment and treatment of binge eating, via assessment of the neurobiological and genetic underpinnings of eating disorders.
55. Van den Eynde F, Guillaume S. Neuromodulation techniques and eating disorders. Int J Eat Disord. 2013 Jul;46(5):447–450. PubMed PMID: 23658089. Epub 2013/05/10. eng. [PubMed] This paper reviews the preliminary evidence supporting the efficacy of neuromodulation techniques with eating disorders and addresses the potential impact of this approach, given the need to address the neurobiological changes associated with eating disorders and the efficacy of neuromodulation with other psychiatric illnesses.
56. Lipsman N, Woodside DB, Giacobbe P, Hamani C, Carter JC, Norwood SJ, et al. Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial. Lancet. 2013 Apr 20;381(9875):1361–1370. PubMed PMID: 23473846. [PubMed] This study presents results from the application of deep brain stimulation—an invasive surgical procedure—to the treatment of eating disorder patients, given the potential benefits of neuromodulation techniques for eating disorder treatment.
57. Treasure J, Schmidt U. DBS for treatment-refractory anorexia nervosa. Lancet. 2013 Apr 20;381(9875):1338–1339. PubMed PMID: 23473848. Epub 2013/03/12. eng. [PubMed]
58. Patel V, Kieling C, Maulik PK, Divan G. Improving access to care for children with mental disorders: a global perspective. Arch Dis Child. 2013;98(5):323–327. PubMed PMID: 23476001. Pubmed Central PMCID: 3672840. [PubMed] This paper describes barriers regarding access to care and identifies strategies for improved training efforts.
59. Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011 Mar;38(2):65–76. PubMed PMID: 20957426. Pubmed Central PMCID: 3068522. Epub 2010/10/20. eng. [PMC free article] [PubMed]
60. Ravitz P, Cooke RG, Mitchell S, Reeves S, Teshima J, Lokuge B, et al. Continuing education to go: capacity building in psychotherapies for front-line mental health workers in underserviced communities. Canadian journal of psychiatry Revue canadienne de psychiatrie. 2013 Jun;58(6):335–343. PubMed PMID: 23768261. [PubMed]
61. Zandberg LJ, Wilson GT. Train-the-trainer: implementation of cognitive behavioural guided self-help for recurrent binge eating in a naturalistic setting. Eur Eat Disord Rev. 2013 May;21(3):230–237. PubMed PMID: 23109361. [PubMed] This demonstration project provides proof-of-concept data for the"train-the-trainer” implementation strategy, which has the potential to significantly increase the number of therapists trained to deliver evidence-based treatments and thus address a critical gap in care delivery.
62. Fairburn CG, Cooper Z. Therapist competence, therapy quality, and therapist training. Behav Res Ther. 2011 Jun;49(6–7):373–378. PubMed PMID: 21492829. Pubmed Central PMCID: 3112491. Epub 2011/04/16. eng. [PMC free article] [PubMed]
63. Wilson GT, Zandberg LJ. Cognitive–behavioral guided self-help for eating disorders: Effectiveness and scalability. Clinical psychology review. 2012;32(4):343–357. [PubMed] This review highlights the efficacy of deploying guided self-help cognitive-behavioral interventions for patients with eating disorders, which is important given the need to conserve person-based resources for those in need of more intensive services.
64. Bauer S, Moessner M. Harnessing the power of technology for the treatment and prevention of eating disorders. Int J Eat Disord. 2013 Jul;46(5):508–515. PubMed PMID: 23658102. Epub 2013/05/10. eng. [PubMed] This review is highly important, as it outlines the use of technology for the prevention and treatment of eating disorders. Technology offers an exciting avenue through which to scale evidence-based interventions or augment existing treatment approaches, thereby increasing the potency of the treatment.
65. Aardoom JJ, Dingemans AE, Spinhoven P, Van Furth EF. Treating eating disorders over the internet: A systematic review and future research directions. Int J Eat Disord. 2013 May;:15. PubMed PMID: 23674367. Epub 2013/05/16. Eng. [PubMed]
66. Shingleton RM, Richards LK, Thompson-Brenner H. Using Technology Within the Treatment of Eating Disorders: A Clinical Practice Review. Psychotherapy (Chicago, Ill) 2013 Mar;:25. PubMed PMID: 23527906. Epub 2013/03/27. Eng. [PMC free article] [PubMed] This review provides a clinical guide to the use of technology within eating disorder treatment delivery.
67. Wilfley DE, Agras WS, Taylor CB. Reducing the burden of eating disorders: A model for population-based prevention and treatment for university and college campuses. Int J Eat Disord. 2013 Jul;46(5):529–532. PubMed PMID: 23658106. Epub 2013/05/10. eng. [PubMed] This paper outlines a novel, comprehensive approach to population-based eating disorder identification and intervention on a college campus, using internet-based tools to conserve person-based resources. The authors discuss its potential impact and offer next steps to further this important work.